|
End-of-day quote
Nasdaq
|
||
| - | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Franck Grimaud
PRN | Corporate Officer/Principal | 59 | 2015-11-30 |
Reinhard Kandera
DFI | Director of Finance/CFO | 56 | - |
Robert C. Seid
PRN | Corporate Officer/Principal | - | 2008-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 87 | 2006-07-04 | |
F. Weller Meyer
BRD | Director/Board Member | 83 | 2005-12-31 |
Richard Douglas
BRD | Director/Board Member | 73 | 2001-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.87% | +3.58% | +44.36% | +0.30% | 82.65B | |
| -0.89% | +0.04% | -19.56% | -36.00% | 60.24B | |
| -2.23% | +3.71% | +478.96% | +34.33% | 58.11B | |
| +1.31% | -1.35% | -7.43% | +30.97% | 49.68B | |
| -0.14% | -2.32% | +1.64% | +153.86% | 46.66B | |
| -1.64% | +1.93% | +56.98% | -15.50% | 32.63B | |
| -0.98% | +2.86% | +46.30% | +99.76% | 25.69B | |
| -1.07% | -2.41% | -1.75% | +186.56% | 22.73B | |
| -1.06% | -3.47% | +62.93% | +106.61% | 16.54B | |
| Average | -0.95% | +0.10% | +73.60% | +62.32% | 43.88B | |
| Weighted average by Cap. | -1.01% | +1.00% | +86.28% | +42.11% |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
